CD274 and cancer: PD-L1 is expressed by cancer cells, dendritic cells, B cells as well as TAMs, indicating pro-tumorigenic function which complicates clarification of the mechanism behind the anti-PD-L1 therapies (Du et al., 2024; Leonard et al., 2024).